Tocqueville Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Sell
465,004
-4,986
-1% -$130K 0.15% 144
2026
Q1
$13.2M Sell
469,990
-48,470
-9% -$1.29M 0.2% 132
2025
Q4
$12.9M Sell
518,460
-53,867
-9% -$1.36M 0.19% 135
2025
Q3
$14.6M Sell
572,327
-24,637
-4% -$608K 0.21% 127
2025
Q2
$14.5M Sell
596,964
-179,834
-23% -$4.19M 0.22% 122
2025
Q1
$19.7M Sell
776,798
-434,537
-36% -$11.4M 0.32% 89
2024
Q4
$32.1M Sell
1,211,335
-166,090
-12% -$4.51M 0.5% 60
2024
Q3
$39.9M Buy
1,377,425
+35,126
+3% +$1.02M 0.63% 44
2024
Q2
$37.6M Sell
1,342,299
-172,454
-11% -$4.75M 0.62% 42
2024
Q1
$42M Buy
1,514,753
+459,613
+44% +$12.8M 0.69% 36
2023
Q4
$30.4M Sell
1,055,140
-136,217
-11% -$4.12M 0.55% 48
2023
Q3
$39.5M Sell
1,191,357
-112,766
-9% -$3.99M 0.75% 31
2023
Q2
$47.8M Buy
1,304,123
+40,726
+3% +$1.59M 0.86% 25
2023
Q1
$51.5M Buy
1,263,397
+77,091
+6% +$3.33M 0.97% 19
2022
Q4
$60.8M Sell
1,186,306
-8,954
-0.7% -$429K 1.15% 14
2022
Q3
$52.3M Sell
1,195,260
-27,883
-2% -$1.35M 1.07% 18
2022
Q2
$64.1M Sell
1,223,143
-33,679
-3% -$1.72M 1.17% 13
2022
Q1
$65.1M Sell
1,256,822
-23,861
-2% -$1.24M 0.98% 19
2021
Q4
$75.6M Sell
1,280,683
-27,098
-2% -$1.34M 1.04% 12
2021
Q3
$56.2M Sell
1,307,781
-69,891
-5% -$3.1M 0.83% 23
2021
Q2
$54M Sell
1,377,672
-190,620
-12% -$7.41M 0.78% 25
2021
Q1
$56.8M Buy
1,568,292
+62,469
+4% +$2.22M 0.87% 21
2020
Q4
$55.4M Sell
1,505,823
-176,881
-11% -$6.49M 0.93% 21
2020
Q3
$58.6M Buy
1,682,704
+93,129
+6% +$3.27M 1.12% 17
2020
Q2
$49.3M Sell
1,589,575
-3,541
-0.2% -$120K 1.03% 18
2020
Q1
$49.3M Buy
1,593,116
+183,198
+13% +$6.24M 1.23% 14
2019
Q4
$52.4M Buy
1,409,918
+23,370
+2% +$832K 0.77% 28
2019
Q3
$47.3M Sell
1,386,548
-66,366
-5% -$2.41M 0.64% 37
2019
Q2
$59.7M Sell
1,452,914
-20,683
-1% -$821K 0.77% 23
2019
Q1
$59.4M Sell
1,473,597
-33,199
-2% -$1.33M 0.79% 21
2018
Q4
$62.4M Sell
1,506,796
-68,462
-4% -$2.84M 0.94% 15
2018
Q3
$65.9M Buy
1,575,258
+7,753
+0.5% +$298K 0.83% 15
2018
Q2
$54M Sell
1,567,505
-95,465
-6% -$3.26M 0.68% 33
2018
Q1
$56M Sell
1,662,970
-202,660
-11% -$6.97M 0.71% 32
2017
Q4
$64.1M Sell
1,865,630
-196,766
-10% -$6.71M 0.73% 32
2017
Q3
$69.9M Sell
2,062,396
-90,207
-4% -$2.9M 0.8% 24
2017
Q2
$68.6M Sell
2,152,603
-36,278
-2% -$1.14M 0.82% 25
2017
Q1
$71M Sell
2,188,881
-242,864
-10% -$7.66M 0.87% 23
2016
Q4
$74.9M Sell
2,431,745
-54,243
-2% -$1.66M 0.96% 20
2016
Q3
$79.9M Buy
2,485,988
+24,443
+1% +$817K 0.96% 23
2016
Q2
$82.2M Sell
2,461,545
-29,018
-1% -$926K 0.98% 20
2016
Q1
$70M Buy
2,490,563
+92,360
+4% +$2.64M 0.93% 21
2015
Q4
$73.4M Buy
2,398,203
+212,398
+10% +$6.68M 1% 18
2015
Q3
$65.1M Buy
2,185,805
+49,457
+2% +$1.59M 0.87% 17
2015
Q2
$68M Buy
2,136,348
+26,898
+1% +$877K 0.8% 20
2015
Q1
$69.6M Buy
2,109,450
+15,613
+0.7% +$496K 0.82% 19
2014
Q4
$61.9M Buy
2,093,837
+103,980
+5% +$2.98M 0.67% 38
2014
Q3
$55.8M Sell
1,989,857
-15,319
-0.8% -$430K 0.62% 40
2014
Q2
$56.5M Sell
2,005,176
-596,576
-23% -$17M 0.55% 50
2014
Q1
$79.3M Sell
2,601,752
-91,572
-3% -$2.73M 1.04% 15
2013
Q4
$78.3M Sell
2,693,324
-28,272
-1% -$823K 1.05% 12
2013
Q3
$74.2M Sell
2,721,596
-128,278
-5% -$3.49M 0.92% 12
2013
Q2
$75.7M Buy
+2,849,874
New +$78.7M 1.03% 11

Other funds holding PFE

Tocqueville Asset Management's PFE Position: Q2 2026 in Review

Tocqueville Asset Management reduced its Pfizer (PFE) stake by 1.1% in Q2 2026, selling an estimated $130K and leaving 465,004 shares worth $11.2M. The position accounts for 0.15% of the portfolio, ranked #144.

Tocqueville Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $82.2M in Q2 2016. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Tocqueville Asset Management held 465,004 shares of Pfizer worth $11.2M as of Q2 2026.
  • Tocqueville Asset Management sold 4,986 Pfizer shares in Q2 2026, an estimated $130K.
  • Pfizer made up 0.15% of Tocqueville Asset Management's portfolio in Q2 2026, its #144 holding.
  • Tocqueville Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Tocqueville Asset Management's Pfizer position peaked at $82.2M in Q2 2016.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.